Scans

Tools

Home

Charts

Watchlist

Products

Pidilite Industries Ltd

PIDILITIND

NSE

₹1,482.60-1.34%19 Oct 2026

Reports

Specialty Chemicals

Pidilite Industries Ltd

PIDILITIND

NSE

₹1,482.60

-1.34%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Specialty Chemicals

Indices

Business Overview: What the company does, in plain English.Growth Catalysts: The forward growth drivers and triggers.Guidance Report: Management guidance vs outcomes.Forensic Report: Accounting quality and red flags.Deep Dive Report: In-depth business analysis.

Pidilite Industries is the company behind some of India’s most ubiquitous household and workshop products - Fevicol, Fevikwik, M-Seal and Dr. Fixit - built over six decades from a single adhesive plant into a multi-engine consumer and industrial chemicals group. It was founded in 1959 and went public in 1993, but the defining move was the deliberate construction of two engines side by side: a Branded Consumer & Bazaar (C&B) division that puts adhesives, sealants and waterproofing into the hands of millions of households and tradespeople, and a Business-to-Business (B2B) division that supplies industrial resins and adhesives to factories. The recurring approach that explains everything else is what management calls “creating values by creating categories” - spotting unmet needs through deep field research, then building brands and distribution around them with sustained, long-term investment rather than chasing quick wins.

Business segments

Three engines at different stages - a consumer-adhesives cash cow, a construction-chemicals growth platform, and an industrial B2B workhorse - each built on the distribution muscle and brand trust of the one before.

1. Consumer & Bazaar Products: the retail engine that puts branded adhesives and sealants into millions of hands

Fevicol alone has been the carpenter’s preferred adhesive since 1965, and the division now sells over 810 products through more than 5,150 distributors reaching over 38,000 towns - a distribution network that turns small-ticket consumables into a recurring revenue machine.

Brands that became verbs - Fevicol, Fevikwik, M-Seal and Dr. Fixit are household names in India, and the company manages its portfolio in three tiers: Core brands targeting steady 1-2X GDP growth, Growth brands like Dr. Fixit and Roff aiming for 2-4X GDP growth, and Pioneer brands like Haisha paints and UnoFin waterproof render chasing entirely new categories.
Distribution that reaches where others don’t - the network spans over 5,150 distributors, 9 regional offices, 4 regional distribution centres, 50 warehouses, and over 13,000 ‘Pidilite ki Duniya’ branded outlets, with rural markets now growing faster than urban ones.
Algorithmic replenishment, not salesmen pushing stock - 80% of major distributors operate on a system where dealers order directly and inventory is managed by an algorithm based on product rotation speed, which eliminated period-end stocking and the discounting that comes with it.
The carpenter is both customer and ambassador - the Fevicol Champion’s Club trains and supports carpenters and contractors, going beyond selling products to offer career counselling for members’ children and financial aid for families in need, while over 20,000 users are engaged for the Roff brand alone.
Innovation that creates new use-cases - recent launches include Fevicol PL444 for premium footwear craftsmen, Fevicol Multi Lock for bonding difficult substrates like acrylic to WPC, and Fevicol Ezeespray, a sprayable adhesive that reaches odd spaces for last-minute finishing.

2. Waterproofing & Construction Solutions: the growth platform riding India’s building boom

India’s tile-adhesive market is worth Rs 2,500-3,000 crores but only 18-20% of users have switched from cement - Pidilite is betting that Dr. Fixit, Roff and a suite of specialist products can convert the rest.

A full-system pitch, not just a product - the portfolio spans waterproofing (Dr. Fixit), tile and stone installation (Roff), construction sealants (Fevi Seal), decorative waterproof render (UnoFin), and paint-plus-waterproofing (Raincoat), covering everything from under-tile waterproofing to crack-bridging exterior coatings in over 1,000 shades.
Bought, not just built - the Roff brand was acquired in 2004, the waterproofing services business came through the purchase of Nina Percept in 2013, and technology partnerships with Litokol (Italy) for epoxy grouts and Grupo Puma (Spain) for mortars brought global formulations to Indian manufacturing.
The applicator network is the moat - over 850 Dr. Fixit centres and a programme of Roff Premium Partners at building-material stores create a physical presence that competitors struggle to replicate, while the company works closely with localised waterproofing applicators and can recommend them to customers.
Services revenue locks in product sales - the wholly owned subsidiary Nina Percept provides waterproofing consultancy and services, and the company also earns from works contracts for residential, industrial and commercial projects, with total recognized services revenue of INR 316.55 crores in FY26.
Going where the construction is - a joint venture in the UAE manufactures construction chemicals, and a new joint venture company in Tanzania (55% stake, incorporated February 2026) will carry the waterproofing and construction-chemicals playbook into East Africa.

3. Business-to-Business: the industrial workhorse supplying factories across a dozen industries

This division makes industrial adhesives, synthetic resins, organic pigments and construction chemicals for large customers in packaging, footwear, automotive, textiles and paints - a quieter engine that runs on technology partnerships and direct relationships rather than retail branding.

Factory-to-factory, not warehouse-to-shop - B2B products are sold directly to industrial customers, with the division contributing 18% of standalone sales across three sub-segments: Industrial Resins and Construction Chemicals (Projects), Industrial Adhesives, and Pigments and Preparations.
Technology partnerships open doors that R&D alone cannot - collaborations with Jowat for joinery adhesives, CollTech for high-precision electronic adhesives (where Pidilite is the exclusive India distributor), and Basic Adhesives and SynBios for leather and electronics applications give the division access to chemistries it would take decades to develop in-house.
The electronics bet is a specification game - in electronic adhesives, the go-to-market process starts with specifications, then sampling and trials, then commercial orders; the company has already secured a few commercial orders and set up a cold chain with Snowman, while the partner CollTech counts 20% of its manpower in R&D and serves large marquee global customers.
Structural consolidation simplified the engine - Pidilite Adhesives Private Limited and Cipy Polyurethanes Private Limited were both amalgamated into the parent company in 2022, streamlining operations and eliminating subsidiary overhead.

Group structure and partners

Pidilite is the listed parent atop 15 domestic subsidiaries, 19 international subsidiaries, 1 international joint venture and 7 associates - a structure built through decades of acquisitions, joint ventures and market entries, then pruned by exiting the Americas entirely in 2024.

International subsidiaries follow the India playbook into similar markets - major operations in Dubai, Bangladesh, Sri Lanka, Thailand and Kenya manufacture and sell adhesives and construction chemicals, with Bangladesh the most developed market after over 15 years of investment, two local plants, and a 21% revenue CAGR over the last decade.
The Americas exit was deliberate - Pidilite USA was wound down and the Brazilian subsidiary Pulvitec was divested to France’s Soprema Group for approximately INR 47 crores in March 2024, concentrating international resources on Asia, the Middle East and Africa where the “India-like” high-touch model works best.
Associates and ventures place bets on adjacencies - the venture arm Pidilite Ventures holds a stake in educational toys (Imagimake, 26.15% stake), while Vinyl Chemicals (40.64%) is a listed chemicals trader and Aapkapainter (47.67%) offers painting and waterproofing solutions.

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹1,51,009Cr

Close Price

₹1,482.60

Industry

Specialty Chemicals

Price To Earnings

56.98

Price To Sales

9.81

Revenue

₹15,399Cr

Rev Gr TTM

Revenue Growth TTM

14.09%

PAT Gr TTM

PAT Growth TTM

21.47%

Upcoming Results on

28 Oct 2026

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	3,076	3,130	2,902	3,395	3,235	3,369	3,141	3,753	3,554	3,710	3,583	4,552
Growth YoY Revenue Growth YoY%	2.1	4.4	7.9	3.7	5.2	7.6	8.3	10.5	9.9	10.1	14.1	21.3
Expenses ExpensesCr	2,396	2,388	2,325	2,583	2,466	2,571	2,509	2,812	2,704	2,815	2,751	3,358
Operating Profit Operating ProfitCr	680	742	577	813	769	798	633	941	851	894	833	1,194
OPM OPM%	22.1	23.7	19.9	23.9	23.8	23.7	20.1	25.1	23.9	24.1	23.2	26.2
Other Income Other IncomeCr	30	37	-25	53	56	55	55	86	50	60	55	109
Interest Expense Interest ExpenseCr	13	13	13	12	12	12	14	14	13	13	14	13
Depreciation DepreciationCr	75	79	113	84	88	90	97	97	100	101	97	97
PBT PBTCr	622	687	426	770	725	752	576	916	787	840	777	1,192
Tax TaxCr	163	177	122	198	185	195	149	238	203	216	193	308
PAT PATCr	459	511	304	571	540	557	428	678	585	624	584	884
Growth YoY PAT Growth YoY%	35.8	66.0	6.5	20.6	17.8	9.0	40.5	18.7	8.2	12.0	36.6	30.3
NPM NPM%	14.9	16.3	10.5	16.8	16.7	16.5	13.6	18.1	16.4	16.8	16.3	19.4
EPS EPS₹	4.4	5.0	3.0	5.6	5.3	5.4	4.2	6.6	5.7	6.1	5.7	8.6

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	3,076	3,130	2,902	3,395	3,235	3,369	3,141	3,753	3,554	3,710	3,583	4,552
Growth YoY Revenue Growth YoY%	2.1	4.4	7.9	3.7	5.2	7.6	8.3	10.5	9.9	10.1	14.1	21.3
Expenses ExpensesCr	2,396	2,388	2,325	2,583	2,466	2,571	2,509	2,812	2,704	2,815	2,751	3,358
Operating Profit Operating ProfitCr	680	742	577	813	769	798	633	941	851	894	833	1,194
OPM OPM%	22.1	23.7	19.9	23.9	23.8	23.7	20.1	25.1	23.9	24.1	23.2	26.2
Other Income Other IncomeCr	30	37	-25	53	56	55	55	86	50	60	55	109
Interest Expense Interest ExpenseCr	13	13	13	12	12	12	14	14	13	13	14	13
Depreciation DepreciationCr	75	79	113	84	88	90	97	97	100	101	97	97
PBT PBTCr	622	687	426	770	725	752	576	916	787	840	777	1,192
Tax TaxCr	163	177	122	198	185	195	149	238	203	216	193	308
PAT PATCr	459	511	304	571	540	557	428	678	585	624	584	884
Growth YoY PAT Growth YoY%	35.8	66.0	6.5	20.6	17.8	9.0	40.5	18.7	8.2	12.0	36.6	30.3
NPM NPM%	14.9	16.3	10.5	16.8	16.7	16.5	13.6	18.1	16.4	16.8	16.3	19.4
EPS EPS₹	4.4	5.0	3.0	5.6	5.3	5.4	4.2	6.6	5.7	6.1	5.7	8.6

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	5,361	5,617	6,078	7,078	7,294	7,293	9,921	11,799	12,383	13,140	14,601	15,399
Growth Revenue Growth%	10.7	4.8	8.2	16.4	3.1	0.0	36.0	18.9	5.0	6.1	11.1	14.1
Expenses ExpensesCr	4,188	4,357	4,737	5,710	5,718	5,612	8,074	9,815	9,676	10,128	11,082	11,627
Operating Profit Operating ProfitCr	1,173	1,260	1,341	1,368	1,576	1,681	1,847	1,984	2,707	3,013	3,519	3,772
OPM OPM%	21.9	22.4	22.1	19.3	21.6	23.1	18.6	16.8	21.9	22.9	24.1	24.5
Other Income Other IncomeCr	81	118	153	132	97	80	48	56	64	219	250	273
Interest Expense Interest ExpenseCr	13	14	16	26	34	37	42	48	51	50	54	54
Depreciation DepreciationCr	100	115	120	133	170	201	240	270	341	358	395	395
PBT PBTCr	1,141	1,248	1,359	1,342	1,470	1,522	1,614	1,723	2,379	2,823	3,320	3,596
Tax TaxCr	334	385	393	413	348	396	407	434	632	727	849	920
PAT PATCr	807	863	966	928	1,122	1,126	1,207	1,289	1,747	2,096	2,471	2,676
Growth PAT Growth%	58.7	6.9	11.9	-3.9	20.9	0.4	7.2	6.8	35.6	20.0	17.9	21.5
NPM NPM%	15.1	15.4	15.9	13.1	15.4	15.4	12.2	10.9	14.1	15.9	16.9	17.4
EPS EPS₹	7.8	8.4	9.5	9.1	11.0	11.1	11.9	12.5	17.0	20.4	24.1	26.0

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	5,361	5,617	6,078	7,078	7,294	7,293	9,921	11,799	12,383	13,140	14,601	15,399
Growth Revenue Growth%	10.7	4.8	8.2	16.4	3.1	0.0	36.0	18.9	5.0	6.1	11.1	14.1
Expenses ExpensesCr	4,188	4,357	4,737	5,710	5,718	5,612	8,074	9,815	9,676	10,128	11,082	11,627
Operating Profit Operating ProfitCr	1,173	1,260	1,341	1,368	1,576	1,681	1,847	1,984	2,707	3,013	3,519	3,772
OPM OPM%	21.9	22.4	22.1	19.3	21.6	23.1	18.6	16.8	21.9	22.9	24.1	24.5
Other Income Other IncomeCr	81	118	153	132	97	80	48	56	64	219	250	273
Interest Expense Interest ExpenseCr	13	14	16	26	34	37	42	48	51	50	54	54
Depreciation DepreciationCr	100	115	120	133	170	201	240	270	341	358	395	395
PBT PBTCr	1,141	1,248	1,359	1,342	1,470	1,522	1,614	1,723	2,379	2,823	3,320	3,596
Tax TaxCr	334	385	393	413	348	396	407	434	632	727	849	920
PAT PATCr	807	863	966	928	1,122	1,126	1,207	1,289	1,747	2,096	2,471	2,676
Growth PAT Growth%	58.7	6.9	11.9	-3.9	20.9	0.4	7.2	6.8	35.6	20.0	17.9	21.5
NPM NPM%	15.1	15.4	15.9	13.1	15.4	15.4	12.2	10.9	14.1	15.9	16.9	17.4
EPS EPS₹	7.8	8.4	9.5	9.1	11.0	11.1	11.9	12.5	17.0	20.4	24.1	26.0

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	513	51	51	51	51	51	51	51	51	51	102
Reserves ReservesCr	2,587	3,420	3,523	4,097	4,405	5,542	6,353	7,161	8,356	9,704	10,730
Current Liabilities Current LiabilitiesCr	915	1,022	1,208	1,301	1,615	2,435	2,325	2,411	2,798	3,290	3,585
Non Current Liabilities Non Current LiabilitiesCr	123	154	247	259	250	563	588	668	689	764	799
Total Liabilities Total LiabilitiesCr	3,719	4,774	5,204	5,915	6,536	8,830	9,516	10,525	12,104	14,011	15,433
Current Assets Current AssetsCr	2,151	3,134	3,309	3,582	3,761	3,515	4,016	4,562	5,836	7,462	8,532
Non Current Assets Non Current AssetsCr	1,568	1,640	1,896	2,333	2,775	5,315	5,500	5,964	6,268	6,549	6,901
Total Assets Total AssetsCr	3,719	4,774	5,204	5,915	6,536	8,830	9,516	10,525	12,104	14,011	15,433

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	513	51	51	51	51	51	51	51	51	51	102
Reserves ReservesCr	2,587	3,420	3,523	4,097	4,405	5,542	6,353	7,161	8,356	9,704	10,730
Current Liabilities Current LiabilitiesCr	915	1,022	1,208	1,301	1,615	2,435	2,325	2,411	2,798	3,290	3,585
Non Current Liabilities Non Current LiabilitiesCr	123	154	247	259	250	563	588	668	689	764	799
Total Liabilities Total LiabilitiesCr	3,719	4,774	5,204	5,915	6,536	8,830	9,516	10,525	12,104	14,011	15,433
Current Assets Current AssetsCr	2,151	3,134	3,309	3,582	3,761	3,515	4,016	4,562	5,836	7,462	8,532
Non Current Assets Non Current AssetsCr	1,568	1,640	1,896	2,333	2,775	5,315	5,500	5,964	6,268	6,549	6,901
Total Assets Total AssetsCr	3,719	4,774	5,204	5,915	6,536	8,830	9,516	10,525	12,104	14,011	15,433

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	907	794	796	845	1,280	1,392	955	1,558	2,724	2,287	2,828
Investing Cash Flow Investing Cash FlowCr	-491	-879	39	-513	103	-1,688	-558	-899	-1,769	-1,542	-1,224
Financing Cash Flow Financing Cash FlowCr	-371	41	-790	-361	-849	-76	-468	-656	-742	-918	-1,673
Net Cash Flow Net Cash FlowCr	45	-45	46	-29	533	-372	-71	2	212	-173	-68
Free Cash Flow Free Cash FlowCr	742	671	620	591	836	1,040	581	1,060	2,171	1,839	2,239
CFO To PAT CFO To PAT%	112.4	92.0	82.4	91.0	114.0	123.6	79.2	120.8	155.9	109.1	114.5
CFO To EBITDA CFO To EBITDA%	77.3	63.0	59.4	61.7	81.2	82.8	51.7	78.5	100.6	75.9	80.4

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	907	794	796	845	1,280	1,392	955	1,558	2,724	2,287	2,828
Investing Cash Flow Investing Cash FlowCr	-491	-879	39	-513	103	-1,688	-558	-899	-1,769	-1,542	-1,224
Financing Cash Flow Financing Cash FlowCr	-371	41	-790	-361	-849	-76	-468	-656	-742	-918	-1,673
Net Cash Flow Net Cash FlowCr	45	-45	46	-29	533	-372	-71	2	212	-173	-68
Free Cash Flow Free Cash FlowCr	742	671	620	591	836	1,040	581	1,060	2,171	1,839	2,239
CFO To PAT CFO To PAT%	112.4	92.0	82.4	91.0	114.0	123.6	79.2	120.8	155.9	109.1	114.5
CFO To EBITDA CFO To EBITDA%	77.3	63.0	59.4	61.7	81.2	82.8	51.7	78.5	100.6	75.9	80.4

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	30,335	35,826	46,642	63,109	68,935	91,973	1,24,803	1,19,647	1,53,333	1,44,929	1,30,859	1,51,009
Price To Earnings Price To Earnings	41.3	41.7	48.5	68.2	61.8	81.3	103.3	94.0	88.7	69.8	53.4	57.0
Price To Sales Price To Sales	5.7	6.4	7.7	8.9	9.4	12.6	12.6	10.1	12.4	11.0	9.0	9.8
Price To Book Price To Book	11.5	10.3	13.1	15.2	15.5	16.4	19.5	16.6	18.2	14.9	12.1	13.9
EV To EBITDA EV To EBITDA	25.8	28.4	34.8	46.1	43.5	54.6	67.6	60.3	56.6	48.1	37.2	40.6
Profitability Ratios Profitability Ratios
GPM GPM%	44.4	51.0	49.7	46.6	50.3	49.6	41.2	39.1	47.4	49.3	50.6	50.6
OPM OPM%	21.9	22.4	22.1	19.3	21.6	23.1	18.6	16.8	21.9	22.9	24.1	24.5
NPM NPM%	15.1	15.4	15.9	13.1	15.4	15.4	12.2	10.9	14.1	15.9	16.9	17.4
ROCE ROCE%	36.3	35.4	37.2	32.1	31.7	26.3	24.3	23.3	27.6	28.1	30.0	30.0
ROE ROE%	26.0	24.9	27.0	22.4	25.2	20.1	18.8	17.9	20.8	21.5	22.8	22.8
ROA ROA%	21.7	18.1	18.6	15.7	17.2	12.8	12.7	12.3	14.4	15.0	16.0	16.0
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	30,335	35,826	46,642	63,109	68,935	91,973	1,24,803	1,19,647	1,53,333	1,44,929	1,30,859	1,51,009
Price To Earnings Price To Earnings	41.3	41.7	48.5	68.2	61.8	81.3	103.3	94.0	88.7	69.8	53.4	57.0
Price To Sales Price To Sales	5.7	6.4	7.7	8.9	9.4	12.6	12.6	10.1	12.4	11.0	9.0	9.8
Price To Book Price To Book	11.5	10.3	13.1	15.2	15.5	16.4	19.5	16.6	18.2	14.9	12.1	13.9
EV To EBITDA EV To EBITDA	25.8	28.4	34.8	46.1	43.5	54.6	67.6	60.3	56.6	48.1	37.2	40.6
Profitability Ratios Profitability Ratios
GPM GPM%	44.4	51.0	49.7	46.6	50.3	49.6	41.2	39.1	47.4	49.3	50.6	50.6
OPM OPM%	21.9	22.4	22.1	19.3	21.6	23.1	18.6	16.8	21.9	22.9	24.1	24.5
NPM NPM%	15.1	15.4	15.9	13.1	15.4	15.4	12.2	10.9	14.1	15.9	16.9	17.4
ROCE ROCE%	36.3	35.4	37.2	32.1	31.7	26.3	24.3	23.3	27.6	28.1	30.0	30.0
ROE ROE%	26.0	24.9	27.0	22.4	25.2	20.1	18.8	17.9	20.8	21.5	22.8	22.8
ROA ROA%	21.7	18.1	18.6	15.7	17.2	12.8	12.7	12.3	14.4	15.0	16.0	16.0
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	PIDILITIND	AETHER	AARTIIND	PRIVISCL	ANURAS	VINATIORGA	SUDEEPPHRM
Market CapitalizationMkt CapCr	1,51,009	20,193	17,375	12,824	12,634	11,596	11,332
Close PriceClose₹	1,482.60	1,521.40	479.00	3,283.00	1,109.70	1,118.60	1,003.30
IndustryIndustry	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals
Price To EarningsPE	56.98	85.62	32.72	36.66	72.15	25.86	60.95
Price To SalesPS	9.81	16.41	1.93	4.80	4.98	4.87	16.77
RevenueRevenueCr	15,399	1,231	9,010	2,671	2,535	2,381	676
Revenue Growth TTMRev Gr TTM%	14.1%	34.4%	27.0%	21.6%	51.8%	5.1%	23.6%
PAT Growth TTMPAT Gr TTM%	21.5%	34.0%	124.0%	62.2%	14.7%	5.4%	20.1%

	PIDILITIND	AETHER	AARTIIND	PRIVISCL	ANURAS	VINATIORGA	SUDEEPPHRM
Market CapitalizationMkt CapCr	1,51,009	20,193	17,375	12,824	12,634	11,596	11,332
Close PriceClose₹	1,482.60	1,521.40	479.00	3,283.00	1,109.70	1,118.60	1,003.30
IndustryIndustry	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals	Specialty Chemicals
Price To EarningsPE	56.98	85.62	32.72	36.66	72.15	25.86	60.95
Price To SalesPS	9.81	16.41	1.93	4.80	4.98	4.87	16.77
RevenueRevenueCr	15,399	1,231	9,010	2,671	2,535	2,381	676
Revenue Growth TTMRev Gr TTM%	14.1%	34.4%	27.0%	21.6%	51.8%	5.1%	23.6%
PAT Growth TTMPAT Gr TTM%	21.5%	34.0%	124.0%	62.2%	14.7%	5.4%	20.1%

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2026

Jun 26